Article
Classifying hepatitis B therapies with insights from covalently closed circular DNA dynamics
16 Dec 2023
Abstract excerpt
The achievement of a functional cure for chronic hepatitis B (CHB) remains limited to a minority of patients treated with currently approved drugs. The primary objective in developing new anti-HBV drugs is to enhance the functional cure rates for CHB. A critical prerequisite for the functional cure of CHB is a substantial reduction, or even eradication of covalently closed circular DNA (cccDNA). Within this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
